Click here to view a
10 minute video of highlights of a CME program presented at the 2007 AHA Scientific Sessions entitled “Advances in the Detection of Rupture-Prone Plaque: The Role of Lp-PLA2 in Cardiovascular Risk Assessment”
Webinar
Click here to view a webinar to learn more about Lipoprotein-associated phospholipase A2 (Lp-PLA2)
Healthcare Professionals
The PLAC® Test is the only blood test cleared by the FDA to aid in assessing risk for both coronary heart disease and ischemic stroke associated with atherosclerosis. Early detection and more aggressive treatment can help prevent these cardiovascular events.
Consistent with ATP III guidelines, the PLAC Test should be used as an adjunct to traditional risk factor assessment to identify which moderate or high risk patients, as initially assessed by traditional risk factors, may actually be at higher risk. Click here to view a decision algorithm to help you see how incorporating the PLAC Test into your clinical practice may help save lives.
The PLAC Test is a simple blood test, it does not require the patient to be fasting and the results are not affected by medications.
Case studies are available to help you learn how the PLAC Test impacts treatment decisions.
The PLAC Facts for healthcare professionals will help you explain the benefits of the PLAC Test to your staff. The PLAC Facts for patients will help you explain the benefits of the test to your patients.
diaDexus offers the turnkey PLAC Essentials Program including all the materials you need to help you incorporate the PLAC Test into your practice. Click here to email us about receiving the PLAC Essentials Program, or with any questions you may have about the PLAC Test. You can also call (877) 752-2837 or (650) 246-6400 with questions or requests.